pathogens. Previously, we showed that respiratory delivery of Modified Vaccinia Virus Ankara-based COVID-19 vaccine candidate, MVA-SARS-2-S, induces protective immune responses against the SARS-CoV-2 in

and, more than any other scientist, represents the special role that science has to play during the COVID 19 pandemic - Professor Dr Christian Drosten, Director of the Institute of Virology at the Charité

represents the interests of German biobanks. What is the BBMRI- ERIC? UAC Sample request form for COVID-19 biobank / HIB projects Please send back the completed UAC Sample Request Form to us. open the Sample

ons in end-stage renal disease (e. g. hyperkalemia, cardiovascular diseases) Complications after COVID-19 You are a patient and interested in clinical studies? If you are interested, we will be happy to

biospecimen storage of the HUB and talked to Prof. Dr. Thomas Illig. The HUB is currently establishing a COVID-19 cohort with 1000 patients and control groups. Additionally, Prof. Dr. Thomas Illig and Prof. Dr

archive you will find all articles on awards and events from 2012 onwards. All relevant information to COVID-19 can be found here. From left to right: Dr. med. Clemens Behrens, Chairman of FRÜHerLEBEN e.V., [...] so much - we are very grateful for this generous donation! PD Dr. Nicolaus Schwerk How useful are COVID vaccinations for children? 02.06.2021 Children between the ages of 12 and 17 can be vaccinated, but

founded in spring 2020. The network is currently bundeling research activities for coping with the COVID-19 pandemic and opening up new strategies for action. Funded by the German Federal Ministry of Education

Manns explained. "Our researchers have been active in and co-founded numerous networks on SARS-CoV-2/COVID-19. And our lecturers have successfully balanced presence and online teaching." Turnover of almost [...] centre in Germany, with 337 organ transplants in 2021." Patient care was significantly affected by COVID-19: "Last year we treated 239 people for a SARS-CoV-2 infection in an intensive care unit, almost [...] 97.2 million euros of acquired third-party funds on research. "The diverse research on SARS-CoV-2/COVID-19 contributed to this: since the beginning of the pandemic, our researchers have raised more than

authors Current third-party funding DFG SFB 1365: Renoprotektion DFG COVID-19 Focus Funding: “Deciphering kidney injury and repair in COVID-19-associated AKI on a single-cell level” BIH and MDC Focus Area

developed for use in biomedical research. "These systems have also already been used, for example in COVID-19 research," says the scientist. The success of the research network is also reflected in the scientific